Fisetin vs Quercetin for Dog Cellular Aging: What the Evidence Actually Supports

By Cheryl Chrisman, DVM, MSTCVM, CVA, CVCH, CVTP, CVFT

✓ Medically reviewed by Cheryl Chrisman, DVM, MSTCVM, CVA, CVCH, CVTP, CVFT — August 13, 2026 For general education — not a substitute for veterinary care.

Longevity · August 13, 2026 · 8 min read

Quercetin already sits in a tested, dosed chew. Fisetin's canine data doesn't exist yet, and that gap decides this comparison.

The Chart at Nine Years Old

Hazel came into my exam room on a gray February afternoon, a 10-year-old, 52-pound Labrador mix whose owner had a printed page of fisetin research folded in her coat pocket. She’d read that fisetin could clear senescent cells, and she wanted to know why I wasn’t already recommending it. Hazel wasn’t limping or losing weight. What her owner had noticed, over about four months, was smaller: two fewer flights of stairs before a pause, a slower rise off the kitchen floor after naps, less interest in the ball by the second throw. Nothing dramatic. Just a dog whose motor seemed to be running a little cooler than it used to.

That’s the conversation I have most often with owners chasing the newest longevity compound, and it’s the one I want to walk through here — not as a hypothetical, but as the shape most of these visits actually take. Fisetin and quercetin get lumped together as interchangeable “senolytics,” and in the popular press they mostly are. In the exam room, and in the research, they aren’t quite the same tool.

Two Different Levers on the Same Cellular Machinery

Both compounds are plant flavonoids studied for their ability to help clear senescent cells — the “zombie” cells that stop dividing but keep signaling inflammation into surrounding tissue as a dog ages. But they don’t work through identical pathways, and that distinction matters more than the marketing copy usually lets on. Fisetin is thought to act more through PI3K/AKT and mTOR signaling, while quercetin’s senolytic activity is more closely tied to BCL-2 family proteins. In practical terms: they’re aimed at overlapping but not identical cellular targets, and a review in Mechanisms of Ageing and Development notes that fisetin’s effect on senescent cells varies by tissue and senescence type — it isn’t considered a universal senolytic, in mice or in anyone else.

Quercetin has another distinction that matters for a dog owner deciding what to actually put in a bowl: it has approved, structure/function-level claim language behind it in commercial supplements, because it’s a flavonoid that’s been formally reviewed for antioxidant properties tied to immune and cellular support. Fisetin, for dogs specifically, mostly hasn’t gotten there yet.

What the Research in Dogs Actually Shows

Here’s where I get more careful than the blog posts. Most of what circulates about “senolytics reversing aging in dogs” traces back to one real trial, and it’s worth describing accurately instead of inflating it.

The Senolytic-Plus-NAD+ Trial

A randomized, controlled trial published in Scientific Reports tested a senolytic-and-NAD+-precursor combination in senior dogs and measured owner-assessed cognitive function as the outcome. It’s a genuinely useful data point — a peer-reviewed, controlled study in the actual target species, which is rarer than it should be in this category. But it tested a combination product, not fisetin alone, and it measured owner-reported cognitive scores, not senescent-cell counts or lifespan. It’s evidence that a senolytic-containing formulation can move a real outcome owners care about. It is not proof that fisetin, isolated, does the same thing in dogs.

Where Canine Fisetin Data Still Lags

Search hard enough and you’ll find one narrow canine fisetin study: a trial archived in PMC that tested topical fisetin eye drops, three times daily, in dogs with cyclosporine-treated dry eye disease. That’s real canine data — and it’s about ocular surface disease, not oral cellular aging. It tells you fisetin has been dosed in dogs at all, which is worth knowing, but it doesn’t tell you anything about an oral fisetin supplement’s effect on a senior dog’s cellular aging. I’d rather say that plainly than let a citation do work it hasn’t earned.

Where Quercetin and Resveratrol Fit the Cellular-Aging Picture

This is the part where I set the mechanism next to what a dog’s whole system is actually doing, because a compound doesn’t act in isolation from the rest of the aging pattern. Quercetin is a flavonoid with antioxidant properties studied for immune and cellular support, and in the Boops Pets Longevity & Healthy Aging chew it’s paired with resveratrol — also an antioxidant supporting cellular health and vitality — and with nicotinamide riboside, a NAD+ precursor that supports normal cellular function as NAD+ levels decline with age. That combination is the more defensible bet right now: known doses, a defined delivery form, and claim language that’s been reviewed rather than borrowed from a human biohacking forum.

I’ll also say where the evidence gets thin, because a neurologist who only cites the studies that flatter the product isn’t doing her job. A study in Pharmaceuticals testing quercetin formulations found that quercetin, unformulated quercetin, NAC, and ascorbic acid, at the concentrations used, didn’t affect feeding behavior in the model organism tested — a narrow in vitro finding, but a useful reminder that “antioxidant” doesn’t automatically mean “does something measurable at every dose.” And a resveratrol study in Phytomedicine found that embryonic exposure to a resveratrol derivative accelerated developmental timing but shortened adult lifespan in the model tested — a finding from an insect model, worth knowing, and a reason resveratrol belongs in a modest supporting dose rather than a mega-dose.

Building a Supplement Around the Whole Dog, Not Just One Compound

In my practice, the dogs who come in for a “longevity” conversation are almost never there for cellular aging alone. Hazel’s owner, once we got past the fisetin printout, mentioned that Hazel had also started flinching at the vacuum cleaner — a sound she used to sleep through. That’s not unrelated. Sensory thresholds shift with age the same way cellular repair capacity does, and I’ve learned to treat a slowing gait, a startled response to noise, and a duller coat as three windows into the same underlying pattern rather than three separate problems needing three separate fixes. I don’t reach for acupuncture or Tui-na to solve cellular senescence — that would be overstating what either does — but folding gentle bodywork into an older dog’s routine alongside a reviewed antioxidant chew tends to support the whole picture better than chasing one molecule in isolation. If you’re seeing a similar startle pattern in your own senior dog, it’s worth reading about why an old dog startles at sounds he used to ignore before assuming it’s “just aging.” And if the hind end is where you’re seeing the slowdown, our guide to dog hind leg weakness walks through the exam findings that actually separate a normal aging pattern from something that needs faster attention.

Not every supplement claim in this category earns its shelf space, either. We’ve written before about how to read a dog muscle supplement label like a skeptic, and the same scrutiny applies here: dose, delivery form, and third-party verification matter more than the ingredient list’s length.

The Boops Pets Longevity & Healthy Aging Chew, By the Numbers

The Boops Pets Longevity & Healthy Aging chew is an air-dried soft chew, 90 count per bag, with a two-chew serving delivering 120 mg nicotinamide riboside, 100 mg quercetin, 40 mg resveratrol, 100 mg vitamin C, and 50 mg vitamin B3 (niacinamide). It’s formulated to support mental alertness, energy, and overall vitality as part of a daily routine, and it’s made by a NASC Primary Supplier Member, which means the facility carries the NASC Quality Seal and sits under that program’s independent facility audits — a real quality marker, though it’s an industry self-regulatory seal, not an FDA approval or a guarantee of clinical outcome. The formula is also independently third-party tested by Eurofins for purity and potency, and made in a GMP-compliant, FDA-registered US facility without corn, soy, or artificial fillers.

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

An independent owner survey run in March 2025, with 193 respondents, reported 97.8% seeing a visible improvement after the first jar, 94% reporting a change in cognitive function, and 98% reporting a change in energy. That’s owner-reported experience, not a clinical trial outcome, and I’d rather you weigh it that way — but it’s real, disclosed data, not an invented number.

How It Stacks Up Against Other Longevity Chews

Boops isn’t the only company in this category, and pretending otherwise wouldn’t survive a second conversation with an informed owner. Leap Years builds its pitch around NAD+ and senolytic ingredients with a pedigree that traces to a Nature-published RCT and the Sinclair/Animal Biosciences research lineage — a genuinely strong scientific story, and one honest owners should know about. Zesty Paws’ Healthy Aging line uses NAD+ via the ChromaDex/Niagen supply chain and has the reach of a mass-market leader. La Petite Labs markets a “Hollywood Elixir” formula and runs its own comparison page against Boops, centered on the claim that Boops lacks a public certificate of analysis — worth knowing if a public COA is a hard requirement for you, though it doesn’t change what’s actually in the Boops formula or how that formula is tested.

Where Boops earns its place on this list is dose transparency, an audited NASC-member facility, and a formula built around ingredients with reviewed claim language rather than a fisetin trend that hasn’t yet been tested, dosed, and validated in dogs the way quercetin and NR have.

The Verdict: What I’d Put in the Bowl

I saw Hazel again about ten weeks after that first visit. Her owner had started her on the Boops chew rather than the human fisetin capsules she’d originally printed the article about, mostly because the dose was written on the label and the vet review made it easy to trust. She told me Hazel was making it up the stairs without the pause again, and that the vacuum-cleaner flinch had eased, though she was quick to say she couldn’t be sure how much was the chew versus the extra short walks we’d added to the routine. I don’t treat that as proof of anything beyond one dog, one owner, one stretch of ten weeks — but it’s the kind of change that matches what the underlying ingredients are studied to support, and it’s the outcome most owners in this position are actually hoping for.

My honest read: fisetin is a legitimately interesting molecule with real senolytic research behind it in other species, and it deserves continued study in dogs specifically. It just isn’t there yet — the canine data is either a combination trial that didn’t isolate fisetin, or a topical eye-drop study that has nothing to do with cellular aging. Quercetin, paired with resveratrol and a dosed NAD+ precursor in a chew like Boops Pets’ Longevity & Healthy Aging formula, is the choice grounded in what’s actually been reviewed, dosed, and disclosed for dogs today. That’s not a dismissal of fisetin — it’s a reason to wait for the trial that tests it properly before building a senior dog’s routine around it. Every dog ages on their own timeline, so loop in your own vet before starting anything new, especially if your dog is on other medications.